Related by context. All words. (Click for frequent words.) 80 oral prodrug 78 AAG geldanamycin analog 78 targeted radiotherapeutic 78 targeted antifolate 77 metaglidasen 77 orally bioavailable 76 Liposomal 76 PEGylated interferon 76 pan HDAC inhibitor 76 vinorelbine tartrate 76 Panzem NCD 76 investigational humanized monoclonal antibody 76 generation purine nucleoside 76 IMiDs R 76 receptor tyrosine kinase inhibitor 76 virus HCV protease inhibitor 76 orally administered inhibitor 76 liposomal doxorubicin 76 dasatinib Sprycel ® 75 PDE4 inhibitor 75 MAGE A3 ASCI 75 reslizumab 75 sodium glucose cotransporter 75 mertansine 75 intranasal formulation 75 histone deacetylase inhibitor 75 ADP receptor antagonist 75 somatostatin analogue 75 TLR9 agonist 75 histone deacetylase HDAC inhibitor 75 selective adenosine 75 vinca alkaloid 75 Tarceva TM 75 dasatinib Sprycel 75 JAK inhibitor 75 non nucleoside inhibitor 75 humanized monoclonal 75 orally inhaled 75 GW# [003] 75 alkylating agent 75 AKT inhibitor 75 anticancer compound 75 Xanafide 75 vapreotide acetate 75 small molecule tyrosine 75 PEGylated Fab fragment 75 paclitaxel Taxol ® 75 proteasome inhibitor 75 Bezielle 75 novel topoisomerase 75 nucleoside analog 75 Orally administered 75 PRT# 75 evaluating tivozanib 74 PSMA ADC 74 selective modulator 74 xanthine oxidase inhibitor 74 gemcitabine cisplatin 74 polymerase inhibitor 74 docetaxel Taxotere R 74 Degarelix 74 IMiDs ® 74 inhaled formulation 74 Temsirolimus 74 histamine dihydrochloride 74 Archexin 74 acetonide FA 74 biomodulator 74 IAP inhibitor 74 selective orally bioavailable 74 HCV protease inhibitors 74 chimeric monoclonal antibody 74 CYT# potent vascular disrupting 74 PI3K/Akt pathway inhibitor 74 MTP inhibitor 74 liposome encapsulated 74 humanized anti 74 proprietary polysaccharide 74 5 HT3 antagonist 74 liposome formulation 74 subcutaneously administered 74 bortezomib Velcade 74 octreotide acetate 74 Fc fusion protein 74 IMiDs ® compound 74 novel VDA molecule 74 2 methoxyestradiol 74 docetaxel Taxotere ® 74 YONDELIS 74 CTAP# Capsules 74 Azedra 74 inhalation powder 73 Onconase 73 Alfacell proprietary ribonuclease 73 Panzem R NCD 73 MKC# 73 Aflibercept 73 IMA# 73 Enkephalin 73 topical gel formulation 73 erlotinib Tarceva ® 73 signal transduction inhibitor 73 Etoposide 73 Amrubicin 73 paclitaxel Taxol 73 sorafenib Nexavar 73 TNF Tumor Necrosis Factor 73 radiation sensitizer 73 Omacetaxine 73 novel histone deacetylase 73 Elvitegravir 73 Luteinizing Hormone Releasing Hormone 73 orally dosed 73 Xeloda ® 73 DNA intercalator 73 gemcitabine Gemzar 73 imatinib Gleevec ® 73 gemcitabine Gemzar ® 73 Panzem R 73 dihydrochloride 73 corticosteroid dexamethasone 73 Mg Usa 73 selective antagonist 73 targeting CD# 73 mTOR inhibitor 73 Irinotecan 73 selective kinase inhibitor 73 anti angiogenic agent 73 PNP inhibitor 73 Zorbtive TM 73 PSN# [001] 73 hormone LHRH antagonist 73 HSP# inhibitor 73 multi kinase inhibitor 73 peripherally acting 73 Gleevec resistant 73 cortisol synthesis 73 volociximab 73 peptibody 73 bevacizumab Avastin R 73 intravesical instillation 73 Thiarabine 73 vidofludimus 73 Traficet EN 73 HCV NS5B polymerase 73 Preclinical studies suggest 73 pan histone deacetylase 73 cetuximab Erbitux R 73 small molecule Hedgehog 73 Fleximer 73 Aeroquin 73 NeuroSTAT ® 73 inhibitor PPI 73 PARI Pharma GmbH 73 Factor VIIa 73 beta 1a 72 TLK# 72 arsenic trioxide injection 72 pharmacologically active isomer 72 ARIKACE ™ 72 Marqibo TM 72 PEGylated anti 72 LymphoStat B belimumab 72 antibody MAb 72 Quinamed 72 long acting muscarinic 72 intravenously administered 72 Tezampanel 72 drug zotarolimus 72 Dabigatran etexilate 72 FOLOTYN ® 72 reversible inhibitor 72 Pemetrexed 72 brand ciclesonide HFA 72 AEGR 72 Pertuzumab 72 nucleotide analog 72 mitogen activated ERK kinase 72 ATL# [002] 72 platelet inhibitor 72 Investigational eFlow Nebulizer System 72 topically applied SEPA 72 novel prodrug 72 Ecallantide 72 Genasense ® oblimersen 72 selective agonist 72 sorafenib tablets 72 cathepsin K inhibitor 72 gefitinib Iressa 72 novel immunomodulatory 72 Blinatumomab 72 VAPRISOL 72 Kahalalide F 72 5 FU leucovorin 72 Tyrima 72 Apoptone 72 HQK 72 ENMD # 72 non nucleoside 72 intranasal delivery 72 Vidaza azacitidine 72 Voreloxin 72 PKC# 72 nucleotide analogue 72 sunitinib Sutent ® 72 small molecule glucokinase 72 CYP#A# CYP#D# 72 angiogenesis inhibitor 72 DiLA2 72 topical gel containing 72 Talabostat 72 PHX# 72 liposomal 72 biodegradable implant 72 Hsp# Inhibitor 72 alvespimycin 72 fosbretabulin 72 Aplidin 72 HuMax EGFr 72 CYT# QbG# 72 highly selective inhibitor 72 TAFA# 72 accumulate preferentially 72 ceftazidime 72 denileukin diftitox 72 protein tyrosine phosphatase 1B 72 humanized antibody 72 refractory chronic lymphocytic 72 Annamycin 72 sunitinib malate 72 thalidomide Thalomid 72 bevacizumab Avastin ® 72 HCV protease 72 Meets Primary Endpoint 72 PrevOnco 72 immune modulatory 72 luteinizing hormone releasing 72 lapatinib Tykerb 72 Personalized Immunotherapy 72 Dapagliflozin 72 entinostat 72 vascular disrupting agents 72 stable nucleic acid 72 Omacetaxine mepesuccinate 72 ZOLINZA 72 rxRNA 72 Anavex #-# 71 Xyfid TM 71 MKC# MKC# PP 71 lenalidomide Revlimid ® 71 cetuximab Erbitux ® 71 Amplimexon 71 BAL# [002] 71 novel emulsion formulation 71 CD4 monoclonal antibody 71 amikacin 71 selective androgen receptor modulator 71 Maribavir 71 demonstrated antitumor activity 71 Dasatinib 71 chemically modified siRNA 71 TO AVOID PREGNANCY WHILE 71 Onalta 71 busulfan 71 PI3K inhibitor 71 Allovectin 7 71 novel oral anticoagulant 71 tumor xenograft models 71 Squalamine 71 pharmacokinetic PK study 71 vascular disrupting agent 71 preclinical efficacy 71 novel DACH platinum 71 Inhalation Solution 71 Bosutinib 71 PDX pralatrexate 71 Carfilzomib 71 monoclonal antibody conjugated 71 Aurora Kinase 71 MKC# MT 71 TBC# 71 CCR5 antagonist 71 HCV protease inhibitor 71 BrachySil TM 71 selective estrogen receptor modulator 71 cisplatin gemcitabine 71 HGS ETR1 mapatumumab 71 microtubule inhibitor 71 CYC# 71 inhaled iloprost 71 SPRYCEL ® 71 NS5B polymerase 71 ATL# [001] 71 IRX 2 71 Pharmacokinetics PK 71 Sym# 71 TRO# 71 nilotinib Tasigna ® 71 CDK inhibitor 71 Phase #b/#a clinical 71 NanoTab 71 Granulocyte Colony Stimulating Factor 71 RhuDex ® 71 HGS ETR2 71 hyaluronidase enzyme 71 pegfilgrastim 71 THR beta agonist 71 anti amnesic 71 XL# XL# 71 Fleximer R 71 erlotinib Tarceva 71 KSP inhibitor 71 OHR/AVR# 71 protein kinase inhibitor 71 isoform selective 71 amrubicin 71 HuMax CD4 71 Alocrest 71 Alexza Staccato 71 oral beclomethasone dipropionate 71 Aztreonam 71 DUROS 71 acyclovir Lauriad R 71 tanespimycin 71 developing Bicifadine serotonin 71 XL# anticancer compounds 71 Methylnaltrexone 71 Civacir 71 iobenguane 71 SinuNase TM 71 delivers fluocinolone acetonide FA 71 CCR9 antagonist 71 Safinamide 71 Presents Preclinical 71 Locteron ® 71 LHRH antagonists 71 Janus Kinase 71 huC# DM4 71 Bortezomib 71 RLY# 71 Octreotide 71 Mg Uk 71 teriflunomide 71 Interferon alpha 71 Ganciclovir 71 Altera Nebulizer System 71 irreversible inhibitor 71 Cetuximab Erbitux 71 JAK inhibitors 71 MYDICAR ® 71 HuLuc# 71 Iluvien ® 71 Glufosfamide 71 Copegus ribavirin 71 fluoropyrimidine 71 Pazopanib 71 Aliskiren 71 Litx 71 Seliciclib 71 Camptosar ® 71 IgG1 monoclonal antibody 71 oral Hsp# inhibitor 71 Angiocept 71 granisetron formulated 71 HepDirect prodrug 71 Aptivus ® 71 oral picoplatin 71 Solulin 71 synthase TS 71 5 Fluorouracil 71 MT# MEDI 71 humanized monoclonal antibody 71 CBLC# 71 JAK2 inhibitor 71 Locked Nucleic Acid LNA 70 AEG# 70 Cloretazine ® 70 ESBA# 70 Nanobody 70 PEGylated 70 standard chemotherapy regimen 70 therapeutic monoclonal antibody 70 MNTX 70 oral anti arrhythmic 70 Tesetaxel 70 induced macular edema 70 chemotherapeutic drug 70 HGS# 70 Presents Preclinical Data 70 Sudhir Agrawal D.Phil 70 ganetespib 70 regorafenib 70 GVAX ® 70 EndoTAG 70 relapsed MM 70 Peginterferon alfa 2b 70 Albuferon TM 70 aleglitazar 70 non nucleoside HCV 70 oxaliplatin Eloxatin 70 CLORETAZINE TM VNP#M 70 pegylated liposomal doxorubicin 70 Pyridorin 70 peptidic compound 70 Moxifloxacin 70 GMX# 70 Hycamtin ® 70 PSN# [002] 70 TG# [003] 70 topoisomerase II inhibitor 70 PEG SN# 70 platinum chemotherapeutic 70 Inhalation Aerosol 70 interferon gamma 1b 70 Evoltra ® 70 lipid nanoparticle 70 somatostatin analog 70 PORxin TM 70 siRNA therapeutic 70 NS#/#A protease 70 MEK inhibitor 70 BRAF inhibitor 70 nanopharmaceutical 70 KRN# 70 novel peptide 70 P#X# antagonist 70 TELINTRA 70 LymphoStat B TM 70 injectable formulation 70 pegylated 70 Camptosar ® irinotecan 70 DermaVir Patch 70 Vidofludimus 70 Pathway Inhibitor 70 Anidulafungin 70 trastuzumab Herceptin R 70 immunomodulating 70 administered subcutaneously 70 nucleoside reverse transcriptase inhibitor 70 NXL# 70 MGd 70 Achieves Primary Endpoint 70 Myolimus 70 lexidronam injection 70 photoprotective drug 70 sufentanil 70 estrogen receptor antagonist 70 trabectedin 70 Nexavar ® 70 systemically administered 70 selective A2A adenosine receptor 70 PEG IFN 70 Randomized Phase 70 SPL# Gel vaginal microbicide 70 liposomal delivery 70 sodium glucose transporter 70 VitiGam 70 Angiotensin Converting Enzyme 70 Elotuzumab 70 Vidaza ® 70 candidate TNFerade biologic 70 cyclophosphamide methotrexate 70 fluocinolone acetonide 70 temsirolimus Torisel ® 70 IL# PE#QQR 70 Fludara ® 70 alfa 2a 70 HuMax 70 phase IIb clinical 70 Oral NKTR 70 Resten NG 70 anti CD3 70 generation antisense 70 antisense oligonucleotide 70 immunotherapeutic agent 70 alpha folate receptor 70 Completes Patient Enrollment 70 CCX# 70 cysteamine bitartrate 70 Guanilib 70 ARIKACE 70 IMiD 70 rhIGF-I/rhIGFBP-3 70 PRTX 70 IMiDs 70 TOCOSOL 70 uricase 70 Taxotere docetaxel 70 renin inhibitor 70 Lenalidomide 70 Cloretazine 70 CD# monoclonal antibody 70 molecular imaging radiopharmaceutical 70 selective inhibitor 70 beta lactamase inhibitor 70 idarubicin 70 YONDELIS R 70 dermal patch 70 oral Factor Xa 70 immune modulating 70 NP2 70 ara C 70 cyclin dependent kinase inhibitor 70 paclitaxel poliglumex 70 bucindolol hydrochloride 70 SinuNase ™ 70 humanised monoclonal antibody 70 Chemophase 70 Palonosetron 70 Arikace 70 ritonavir boosted 70 Ambrisentan 70 VNP#M 70 Taxol ® 70 antibody fragment 70 amphotericin B 70 metastatic malignant 70 HCD# [002] 70 treat male hypogonadism 70 multicenter Phase II 70 R Saizen R 70 indibulin 70 Cleviprex TM clevidipine 70 Pimavanserin 70 TRX1 70 immunotherapeutic vaccine 70 OncoVEX GM CSF 70 Sapacitabine 70 tenofovir disoproxil fumarate Viread 70 candidate deforolimus 70 Gleevec imatinib mesylate 70 TKB# 70 Plicera 70 Intravail R 70 investigational pharmacologically unique 70 SAR# [002] 70 immunostimulatory 70 monoclonal antibody IgG1 Mab 70 Serostim ® 70 mTOR mammalian target 70 tiuxetan 70 Rigel R# 70 investigational monoclonal antibody 70 FEMALES SHOULD BE ADVISED 70 Biolimus A9 70 selective immunoproteasome inhibitor 70 systemic RNAi therapeutic 70 Mipomersen 70 D aspartate NMDA receptor 70 tyrosine kinase inhibitor 70 Topotecan 70 nucleoside analogs 70 ATRA IV 70 mda 7 70 sublingual formulation 70 topical antifungal 70 Anticalins R 70 neuronal nicotinic receptor NNR 70 Leukine ® 70 topical formulation 70 cidofovir 70 hormone agonist 70 angiotensin receptor blocker ARB 70 sitaxsentan 70 JAK1 70 lucinactant 70 GRNVAC1 70 Ophena TM 70 RECOTHROM R 70 fludarabine phosphate 70 CCX# B 70 Symadex 70 CoFactor 70 Copegus ® 70 target enzyme thymidylate 70 Spiegelmer ® 70 PrevOnco ™ 70 CIMZIA TM 70 HCV replicon 70 small molecule activators 69 plasma kallikrein inhibitor 69 oral rivaroxaban 69 abacavir lamivudine 69 Neulasta ® 69 Pegasys ® 69 afamelanotide 69 methylnaltrexone bromide 69 Vinorelbine 69 ocular formulation 69 CINTREDEKIN BESUDOTOX 69 XmAb ™ 69 CD# antibody [001] 69 melphalan prednisone 69 oral antiviral 69 bendamustine 69 potent CYP#A# inhibitors 69 oral dihydropyrimidine dehydrogenase DPD 69 peptide conjugated 69 omega interferon 69 Phase 1b clinical trials 69 VEGFR2 inhibitor 69 Fodosine 69 Fenretinide 69 Vascugel 69 selectively inhibits 69 Capesaris 69 VISICOL R 69 Epratuzumab 69 SERMs 69 Exherin 69 Bruton tyrosine kinase Btk 69 highly selective endothelin 69 INT# [002] 69 CINQUIL 69 Ziprasidone 69 mu opioid receptor antagonist 69 Aztreonam lysine 69 sulfonylhydrazine class 69 Intravenous Human 69 oral ridaforolimus 69 XmAb# 69 cilengitide 69 anticancer agent 69 topically administered 69 Cannabinor 69 Doxorubicin 69 docetaxel Taxotere 69 hA# 69 FOLFOX6 chemotherapy regimen 69 CIMZIA ™ 69 Zalypsis 69 Inhalation Powder 69 CD3 monoclonal antibody 69 non peptidic protease 69 hPTH #-# 69 Virulizin ® 69 leading oral taxane 69 EOquin TM 69 NUVIGIL ® 69 Elagolix 69 M1 muscarinic 69 panitumumab Vectibix 69 Neulasta R 69 trastuzumab DM1 T DM1 69 Platinol 69 delafloxacin 69 cytostatic 69 Pafuramidine 69 Dalbavancin 69 hypoxia activated prodrug 69 Lubiprostone 69 herpetic keratitis 69 proteasome inhibitor bortezomib 69 mitomycin 69 mesylate 69 antimitotic 69 lenalidomide Revlimid R 69 Clevudine 69 potent antiproliferative 69 Epidermal Growth Factor Receptor 69 q8h 69 mGluR5 negative 69 SYN# 69 subcutaneous formulation 69 sargramostim 69 Aganocide 69 Platinol ® cisplatin 69 pharmacodynamic properties 69 interferon alfa 69 pertuzumab 69 Phase IIb clinical trials 69 SNALP technology 69 elotuzumab 69 thymalfasin 69 favorable pharmacokinetic profile 69 Dual Opioid 69 MEK inhibitors 69 immunomodulatory 69 immunomodulator 69 Intravenous CP 69 diclofenac sodium 69 prescribed proton pump 69 Silodosin 69 Interferon beta 69 Vaprisol 69 Initiates Phase II 69 Clolar ® 69 immune modulator 69 lipoglycopeptide 69 Locked Nucleic Acid 69 Micromet BiTE 69 Dacogen decitabine 69 Trastuzumab 69 taxane resistant 69 muscarinic antagonist 69 Survivin antagonist 69 selective inhibition 69 hypoxia selective 69 BiTE 69 hyperphenylalaninemia HPA due 69 investigational oral inhibitor 69 Saizen ® 69 Mycophenolate Mofetil 69 Polymer Microspheres 69 miconazole Lauriad R 69 TLR agonists 69 SGLT 69 nilotinib Tasigna 69 synthetic retinoid 69 miconazole Lauriad ® 69 Zybrestat 69 XP# XP# 69 compound perifosine 69 MOVIPREP R 69 Atripla combines 69 Aviptadil 69 Daclizumab 69 ALN TTR# 69 subcutaneous SC 69 pain palliation 69 pioglitazone HCl 69 Saquinavir 69 solithromycin 69 candidates Azedra TM 69 torezolid phosphate 69 LHRH antagonist 69 investigational oral hepatitis C 69 radiotherapeutic 69 modulator SERM 69 potently inhibit 69 azacytidine 69 HCV RNA polymerase 69 receptor inhibitor 69 Gemzar ® 69 histone deacetylase HDAC 69 antisense drug 69 LAB CGRP 69 Cyclosporine 69 HDAC Inhibitor 69 Lixivaptan 69 Curaxin CBLC# 69 efaproxiral 69 Transdrug ® nanoparticle 69 Teysuno 69 Icatibant 69 polysaccharide polymer 69 SNT MC# 69 HuMax TAC 69 Vicinium TM 69 Yondelis ® 69 sapropterin dihydrochloride 69 ospemifene 69 DAVANAT 69 Melphalan 69 dopamine partial agonist 69 Bendamustine 69 Vidaza R 69 Enhanze Technology 69 Telmisartan 69 Recombinant Human 69 RNA antagonist 69 Epirubicin 69 immunomodulatory therapy 69 plus prednisone prednisolone 69 BAY #-# 69 protease inhibitor PI 69 antimetabolite 69 DepoVax TM 69 Vascular Disrupting Agent 69 Protein Kinase C 69 drug ISA# 69 Nexavar sorafenib 69 relapsed refractory multiple myeloma 69 phase III isavuconazole 69 NB S# strontium malonate 69 EXPAREL TM 69 Radiation Therapy SIRT 69 gemtuzumab ozogamicin 69 BiTE R 69 HCV NS3 protease 69 Novel Oral 69 novel nucleoside analog 69 oral transmucosal 69 anionic backbone 69 Fulvestrant 69 personalized immunotherapy 69 Denufosol 69 Besivance 69 potent topoisomerase II 69 Peginterferon 69 antifolate 69 rHuPH# recombinant human 69 xenograft models 69 Aplidin R 69 Ceflatonin 69 Mitoxantrone 69 MVA BN R 69 Bruton tyrosine kinase 69 5 HT4 69 Azacitidine 69 MEK Inhibitor 69 Kinase Inhibitor 69 radezolid 69 OMP #M# 69 AFREZZA TM 69 generation antisense inhibitor 69 DexaSite 69 potent inhibitor 69 Varespladib 69 orally inhaled migraine 69 boosted protease inhibitor 69 EndoTAG TM 69 visilizumab 69 Teriflunomide 69 Abiraterone acetate 69 topical ophthalmic 69 insulin sensitizing 69 cytarabine daunorubicin 69 ALN PCS 69 erlotinib Tarceva R 69 FUSILEV enhances 69 transdermal spray 69 ® lenalidomide 69 IAP inhibitors 69 Immunotherapeutic 69 Anticalins ® 69 Cetrorelix 69 aurora kinase 69 Captisol Enabled 69 CorVue ™ 69 Bicalutamide 69 ancrod 69 Paraplatin ® 69 Xcellerated T Cells 69 taxane derivative 69 bortezomib Velcade R 69 agonistic human 69 apoptosis inducers 69 estramustine 69 receptor blocker 69 gemcitabine carboplatin 69 TRISENOX ® 69 Phase 1a clinical 69 obatoclax 69 FDA APPROVES 69 mecamylamine 69 EZN 69 quinolone 69 Phase Ib study 69 bazedoxifene selective estrogen receptor 69 Prodrug 69 sorafenib Nexavar ® 69 oblimersen 69 #mg/#mg 69 inhibitor RG# 69 Parathyroid Hormone 69 DCCR 69 OncoVEX 69 GLP1 agonist 69 ixabepilone 69 dimeglumine 69 antibody MT# 69 proteasome inhibitors 69 cleavable linker 69 oral talactoferrin 69 Thiovir 69 small molecule chemotherapeutic 69 tyrosine kinase inhibitor TKI 69 imexon 69 agonist LABA 69 direct thrombin inhibitors 69 nasal spray formulation 69 etanercept Enbrel 69 radiolabeled 69 Myocet 69 rilonacept 69 Panzem 69 patented Bioral 69 echinocandin 69 phase IIb trial 69 Letairis ambrisentan 69 retaspimycin hydrochloride 69 Piperacillin 69 HepaGam B 69 angiotensin II receptor blocker 69 R sorafenib tablets 69 2A receptor agonist 69 Alkeran 69 Diabetic Macular Edema DME 69 NMDA antagonist 69 Initiate Phase 69 Rebif ® 69 ulimorelin 69 GTC recombinant human 69 Pralatrexate 69 MGN# 69 Kamada AAT 69 Zavesca R 69 dextromethorphan quinidine 69 antagonist LAMA 69 sulodexide 69 Phase IIb Trial 69 ibritumomab tiuxetan 69 ALN HPN 69 temsirolimus Torisel 68 maximally tolerated dose 68 insulin sensitizer 68 biologic DMARD 68 Ceflatonin R 68 somatostatin analogues 68 neratinib 68 Belerofon 68 epothilone 68 rALLy clinical trial 68 SUTENT ® 68 granisetron 68 siRNA binds 68 intravesical infusion therapy 68 Transported Prodrug 68 Gefitinib 68 LEP ETU 68 Tasimelteon 68 alefacept 68 rituximab Rituxan 68 E1 INT TM 68 effector function 68 OncoGel 68 oxybutynin gel 68 ZEVALIN ® 68 multikinase inhibitor 68 NanoEmulsion 68 tumor vascular disrupting 68 Iluvien TM 68 octreotide implant 68 PolyActive ® 68 irinotecan doxorubicin oxaliplatin paclitaxel 68 KNS # 68 including eniluracil ADH 68 ChronVac C R 68 delta opioid receptor 68 Nilotinib 68 vinca alkaloids 68 huN# DM1 68 CG# [003] 68 Epothilone D 68 Lauriad R 68 oral ghrelin agonist 68 lintuzumab SGN 68 kidney urologic 68 fluoroquinolone antibiotic 68 diarrhea predominant irritable 68 Navelbine ® 68 TriRima 68 pomalidomide 68 formoterol fumarate 68 5 HT3 receptor 68 SPC# [001] 68 Tumor Necrosis Factor 68 LAF# 68 successfully commercialize Iluvien 68 ALK inhibitor 68 Erlotinib 68 exon skipping 68 anti emetic therapy 68 Initiates Enrollment 68 Receives Orphan Drug Designation 68 immune stimulatory 68 Investigational Oral 68 cutaneous T 68 Cyclosert 68 monoclonal antibody MAb 68 acyclovir Lauriad ® 68 RAV# 68 Ixempra 68 Darunavir 68 immunotoxin 68 Bicifadine 68 ciprofloxacin hydrochloride 68 apoptosis inducer 68 daunorubicin 68 allosteric modulator NAM 68 Kuvan sapropterin dihydrochloride 68 BENLYSTA ® 68 Abbokinase 68 cinacalcet 68 oral chemotherapeutic agent 68 ribavirin RBV 68 oral nucleoside analogue 68 Enzyme Replacement Therapy 68 meropenem 68 M# rationally 68 interferon IFN 68 OvaRex ® MAb 68 G#DT 68 phase IIa clinical 68 Intravitreal 68 alkylating 68 Opterone R 68 paclitaxel Taxol R